Nu Med Plus Stock Chance of Future OTC Stock Price Finishing Over 0.012
| NUMD Stock | USD 0.01 0 10.00% |
NUMD |
Nu Med Target Price Odds to finish over 0.012
The tendency of NUMD OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 0.01 in 90 days |
| 0.01 | 90 days | 0.01 | about 89.61 |
Based on a normal probability distribution, the odds of Nu Med to stay above $ 0.01 in 90 days from now is about 89.61 (This Nu Med Plus probability density function shows the probability of NUMD OTC Stock to fall within a particular range of prices over 90 days) . Probability of Nu Med Plus price to stay between $ 0.01 and its current price of $0.0126 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days Nu Med Plus has a beta of -1.92. This indicates as returns on its benchmark rise, returns on holding Nu Med Plus are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Nu Med is expected to outperform its benchmark. Additionally Nu Med Plus has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Nu Med Price Density |
| Price |
Predictive Modules for Nu Med
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nu Med Plus. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Nu Med Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Nu Med is not an exception. The market had few large corrections towards the Nu Med's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nu Med Plus, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nu Med within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.15 | |
β | Beta against Dow Jones | -1.92 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.1 |
Nu Med Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nu Med for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nu Med Plus can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nu Med Plus generated a negative expected return over the last 90 days | |
| Nu Med Plus has high historical volatility and very poor performance | |
| Nu Med Plus has some characteristics of a very speculative penny stock | |
| Nu Med Plus currently holds 2.06 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Nu Med Plus has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nu Med until it has trouble settling it off, either with new capital or with free cash flow. So, Nu Med's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nu Med Plus sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NUMD to invest in growth at high rates of return. When we think about Nu Med's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (830.06 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nu Med Plus currently holds about 2.54 K in cash with (206.83 K) of positive cash flow from operations. | |
| Roughly 62.0% of Nu Med outstanding shares are owned by corporate insiders |
Nu Med Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NUMD OTC Stock often depends not only on the future outlook of the current and potential Nu Med's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nu Med's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 79.3 M | |
| Shares Float | 27.7 M |
Nu Med Technical Analysis
Nu Med's future price can be derived by breaking down and analyzing its technical indicators over time. NUMD OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nu Med Plus. In general, you should focus on analyzing NUMD OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Nu Med Predictive Forecast Models
Nu Med's time-series forecasting models is one of many Nu Med's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nu Med's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Nu Med Plus
Checking the ongoing alerts about Nu Med for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nu Med Plus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nu Med Plus generated a negative expected return over the last 90 days | |
| Nu Med Plus has high historical volatility and very poor performance | |
| Nu Med Plus has some characteristics of a very speculative penny stock | |
| Nu Med Plus currently holds 2.06 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Nu Med Plus has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nu Med until it has trouble settling it off, either with new capital or with free cash flow. So, Nu Med's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nu Med Plus sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NUMD to invest in growth at high rates of return. When we think about Nu Med's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (830.06 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nu Med Plus currently holds about 2.54 K in cash with (206.83 K) of positive cash flow from operations. | |
| Roughly 62.0% of Nu Med outstanding shares are owned by corporate insiders |
Other Information on Investing in NUMD OTC Stock
Nu Med financial ratios help investors to determine whether NUMD OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NUMD with respect to the benefits of owning Nu Med security.